Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
114 participants
OBSERVATIONAL
2020-07-01
2021-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Obesity: an Underappreciate Risk Factor for Severe Form of COVID-19
NCT05771857
Safety and Immune Response of COVID-19 Vaccination in Overweight People With Excessive BMI
NCT05043272
Association Between BMI and COVID-19
NCT04391738
Effect of Obesity Among COVID-19 Patients in Critical Care Settings
NCT04674553
Impact of Adipose Tissue in COVID-19
NCT04639440
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
prospective cohort in high body mass index patient with covid 19
A cohort study included 114 adult patients with confirmed COVID-19 were categorized by BMI levels
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* confirmed COVUID 19 infection
* body mass index more than 25kg/m2
Exclusion Criteria
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
South Valley University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gad Sayed Gad
ass.prof anesthesia department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gad S Gad, phd
Role: PRINCIPAL_INVESTIGATOR
ass prof ,anesthesia and ICU ,south valley university,Qena .Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gad sayed Gad
Qina, Qena Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BMI_COVID19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.